17-AAG
Term · Oncology and biomedicine · MLC-T-ONC-000014
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.
| Identifier | MLC-T-ONC-000014 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | 17-N-allylamino-17-demethoxygeldanamycin; tanespimycin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000014",
"term": "17-AAG",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.",
"expansions": [
"17-N-allylamino-17-demethoxygeldanamycin",
"tanespimycin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/17-aag/"
}
Record 22 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.